Martin Griffin

Birmingham, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Correction: A novel extracellular role for tissue transglutaminase in matrix-bound VGF-mediated angiogenesis.

Correction: A novel extracellular role for tissue transglutaminase in matrix-bound VGF-mediated angiogenesis.

Journal: Cell death & disease

Published: May 13, 2026

Inhibition of Transglutaminase 2 by a Selective Small Molecule Inhibitor Reduces Fibrosis and Improves Pulmonary Function in a Bleomycin Mouse Model.

Inhibition of Transglutaminase 2 by a Selective Small Molecule Inhibitor Reduces Fibrosis and Improves Pulmonary Function in a Bleomycin Mouse Model.

Journal: Cells

Published: February 17, 2025

Biochemical and Functional Characterization of the Three Zebrafish Transglutaminases 2.

Biochemical and Functional Characterization of the Three Zebrafish Transglutaminases 2.

Journal: International journal of molecular sciences

Published: July 05, 2023

Corrigendum: CDKN2A determines mesothelioma cell fate to EZH2 inhibition.

Corrigendum: CDKN2A determines mesothelioma cell fate to EZH2 inhibition.

Journal: Frontiers in oncology

Published: October 27, 2022

Nitrosylation of tissue transglutaminase enhances fibroblast migration and regulates MMP activation.

Nitrosylation of tissue transglutaminase enhances fibroblast migration and regulates MMP activation.

Journal: Matrix biology : journal of the International Society for Matrix Biology

Published: July 13, 2021

CDKN2A Determines Mesothelioma Cell Fate to EZH2 Inhibition.

CDKN2A Determines Mesothelioma Cell Fate to EZH2 Inhibition.

Journal: Frontiers in oncology

Published: March 09, 2021

Transglutaminase 2: a novel therapeutic target for idiopathic pulmonary fibrosis using selective small molecule inhibitors.

Transglutaminase 2: a novel therapeutic target for idiopathic pulmonary fibrosis using selective small molecule inhibitors.

Journal: Amino acids

Published: September 03, 2020

Neurite outgrowth inhibitory levels of organophosphates induce tissue transglutaminase activity in differentiating N2a cells: evidence for covalent adduct formation.

Neurite outgrowth inhibitory levels of organophosphates induce tissue transglutaminase activity in differentiating N2a cells: evidence for covalent adduct formation.

Journal: Archives of toxicology

Published: January 19, 2020

Transglutaminase 2 maintains a colorectal cancer stem phenotype by regulating epithelial-mesenchymal transition.

Transglutaminase 2 maintains a colorectal cancer stem phenotype by regulating epithelial-mesenchymal transition.

Journal: Oncotarget

Published: May 03, 2019

Cardiac fibrosis can be attenuated by blocking the activity of transglutaminase 2 using a selective small-molecule inhibitor.

Cardiac fibrosis can be attenuated by blocking the activity of transglutaminase 2 using a selective small-molecule inhibitor.

Journal: Cell death & disease

Published: January 20, 2018

The functional relationship between transglutaminase 2 and transforming growth factor β1 in the regulation of angiogenesis and endothelial-mesenchymal transition.

The functional relationship between transglutaminase 2 and transforming growth factor β1 in the regulation of angiogenesis and endothelial-mesenchymal transition.

Journal: Cell death & disease

Published: March 08, 2017

Tissue transglutaminase (TG2) enables survival of human malignant pleural mesothelioma cells in hypoxia.

Tissue transglutaminase (TG2) enables survival of human malignant pleural mesothelioma cells in hypoxia.

Journal: Cell death & disease

Published: October 20, 2016

Showing 1-12 of 29

Last Updated: 09/26/2026